{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:37:24Z","timestamp":1793320644926,"version":"4.5.0"},"reference-count":34,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JHU\/imCORE Scientific Alliance","award":["137515"],"award-info":[{"award-number":["137515"]}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","award":["137515"],"award-info":[{"award-number":["137515"]}],"id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although immune checkpoint inhibitors (ICIs) have long half-lives, preclinical and retrospective clinical studies across multiple tumor types suggest that the time-of-day of ICI infusion may influence therapeutic efficacy by aligning initial drug exposure with circadian peaks in T-cell responsiveness. The immunological basis of this phenomenon and its clinical relevance in hepatocellular carcinoma (HCC) remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We followed patients with advanced HCC receiving ICI therapy at Johns Hopkins from 2021 to 2025, classifying them into a morning (first treatment before 12:00 hours) or afternoon (first treatment after 12:00 hours) group. We assessed clinical outcomes and compared immunological responses from baseline to early-on-treatment by profiling peripheral blood mononuclear cells using cytometry by time-of-flight and plasma cytokines using a 39-plex Luminex assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our cohort included 84 patients, 39 of whom received their first infusion in the morning. There were no statistically significant differences in baseline demographic or clinical characteristics between patients initiating therapy in the morning versus afternoon. The morning group had superior progression-free survival (multivariable HR 0.50, 95% CI 0.30 to 0.84, p&lt;0.01) and higher odds of treatment response (multivariable OR 3.26, 95% CI 1.08 to 10.90, p&lt;0.05), with no significant increase in immune-related adverse events. The timing of subsequent infusions after the first dose had no impact on outcomes. Immunological responses diverged after the initial dose, with morning-treated patients showing reduced interleukin (IL)-6 levels (p&lt;0.01) and greater expansion of cytotoxic central memory CD8+ T\u2009cells (p=0.01) as well as cytotoxic effector and effector memory CD8+ T\u2009cells (p=0.06).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Morning first-dose infusion of ICIs in HCC was associated with improved clinical outcomes and distinct immune responses, including reduced IL-6 signaling and expansion of cytotoxic central memory CD8+ T cells. These findings suggest that the timing of the initial infusion can imprint an immunological program that shapes subsequent antitumor immunity, providing a mechanistic rationale for strategically scheduling ICI administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-014070","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:25:20Z","timestamp":1776803120000},"page":"e014070","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2223-5444","authenticated-orcid":false,"given":"Howard L","family":"Li","sequence":"first","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren","family":"Charmsaz","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Reisman","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-6438","authenticated-orcid":false,"given":"Franshisca","family":"Hayek","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelena","family":"Brancati","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Leatherman","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pazzi","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce P","family":"Lee","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Christenson","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqar","family":"Arif","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeric","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ellis","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E","family":"Gross","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-9183","authenticated-orcid":false,"given":"Chris","family":"Thoburn","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-9906","authenticated-orcid":false,"given":"G Scott","family":"Chandler","sequence":"additional","affiliation":[{"name":"F Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4233-5210","authenticated-orcid":false,"given":"Rajat","family":"Mohindra","sequence":"additional","affiliation":[{"name":"F Hoffmann-La Roche Ltd, Basel, Switzerland"},{"name":"Genentech Inc, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bansal","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tang","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Guha","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi V","family":"Dang","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"},{"name":"Ludwig Institute for Cancer Research, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeha","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M","family":"Jaffee","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Laheru","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Zabransky","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-2405","authenticated-orcid":false,"given":"Marina","family":"Barretti","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-5086","authenticated-orcid":false,"given":"Won Jin","family":"Ho","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026042113251736000_14.4.e014070.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"2026042113251736000_14.4.e014070.2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367"},{"key":"2026042113251736000_14.4.e014070.3","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00748-2"},{"key":"2026042113251736000_14.4.e014070.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113571"},{"key":"2026042113251736000_14.4.e014070.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102220","article-title":"Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis","volume":"9","author":"Landr\u00e9","year":"2024","journal-title":"ESMO Open"},{"key":"2026042113251736000_14.4.e014070.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00546-5"},{"key":"2026042113251736000_14.4.e014070.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01690"},{"key":"2026042113251736000_14.4.e014070.8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040896","article-title":"Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer","volume":"14","author":"Karabou\u00e9","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026042113251736000_14.4.e014070.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02704-9"},{"key":"2026042113251736000_14.4.e014070.10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008011","article-title":"Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis","volume":"12","author":"Patel","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026042113251736000_14.4.e014070.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105607","article-title":"Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study","volume":"113","author":"Huang","year":"2025","journal-title":"EBioMedicine"},{"key":"2026042113251736000_14.4.e014070.12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood.2025031476","article-title":"Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma","volume":"147","author":"Luan","year":"2026","journal-title":"Blood"},{"key":"2026042113251736000_14.4.e014070.13","doi-asserted-by":"crossref","unstructured":"Huang Z , Zeng L , Ruan Z , et al . Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial. Nat Med 2026;2. doi:10.1038\/s41591-025-04181-w","DOI":"10.1038\/s41591-025-04181-w"},{"key":"2026042113251736000_14.4.e014070.14","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1158\/0008-5472.CAN-24-2083","article-title":"Clocking Cancer Immunotherapy Responses","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res"},{"key":"2026042113251736000_14.4.e014070.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.015"},{"key":"2026042113251736000_14.4.e014070.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029801","article-title":"Circadian clocks in mouse and human CD4+ T cells","volume":"6","author":"Bollinger","year":"2011","journal-title":"PLoS One"},{"key":"2026042113251736000_14.4.e014070.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.10.007"},{"key":"2026042113251736000_14.4.e014070.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.12.011"},{"key":"2026042113251736000_14.4.e014070.19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.2200516","article-title":"Regulation of Cytotoxic CD8+ T Cells by the Circadian Clock","volume":"210","author":"Cermakian","year":"2023","journal-title":"J Immunol"},{"key":"2026042113251736000_14.4.e014070.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-190769"},{"key":"2026042113251736000_14.4.e014070.21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176567","article-title":"Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures","volume":"134","author":"Kao","year":"2024","journal-title":"J Clin Invest"},{"key":"2026042113251736000_14.4.e014070.22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009734","article-title":"Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade","volume":"13","author":"Alden","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026042113251736000_14.4.e014070.23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2326-6066.CIR-24-1055","article-title":"Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines","volume":"13","author":"Nakazawa","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"2026042113251736000_14.4.e014070.24","doi-asserted-by":"crossref","unstructured":"Li HL , Charmsaz S , Nakazawa M , et al . Supplemental Table 1 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy. Cancer Res Commun 2025. doi:10.1158\/2767-9764.30256038","DOI":"10.1158\/2767-9764.30256038"},{"key":"2026042113251736000_14.4.e014070.25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.2024.42.3_suppl.457","article-title":"Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma","volume":"42","author":"Pascale","year":"2024","journal-title":"JCO"},{"key":"2026042113251736000_14.4.e014070.26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011145","article-title":"PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy","volume":"13","author":"Moseman","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026042113251736000_14.4.e014070.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0441-y"},{"key":"2026042113251736000_14.4.e014070.28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004030"},{"key":"2026042113251736000_14.4.e014070.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100672","article-title":"High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"JHEP Rep"},{"key":"2026042113251736000_14.4.e014070.30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007530","article-title":"New perspectives in cancer immunotherapy: targeting IL-6 cytokine family","volume":"11","author":"Soler","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026042113251736000_14.4.e014070.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165799","article-title":"Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis","volume":"11","author":"Nilsonne","year":"2016","journal-title":"PLoS One"},{"key":"2026042113251736000_14.4.e014070.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34897-z","article-title":"The circadian clock influences T cell responses to vaccination by regulating dendritic cell antigen processing","volume":"13","author":"Cervantes-Silva","year":"2022","journal-title":"Nat Commun"},{"key":"2026042113251736000_14.4.e014070.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.048"},{"key":"2026042113251736000_14.4.e014070.34","doi-asserted-by":"crossref","first-page":"112183","DOI":"10.1016\/j.celrep.2023.112183","article-title":"Disturbed rhythmicity of intestinal hydrogen peroxide alters gut microbial oscillations in BMAL1-deficient monkeys","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-014070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:25:24Z","timestamp":1776803124000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-014070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/jitc-2025-014070"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-014070","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}